Detalles de la búsqueda
1.
Liver failure after treatment with inotuzumab and polychemotherapy including PEG-asparaginase in a patient with relapsed Philadelphia chromosome-negative acute lymphoblastic leukemia.
Ann Hematol
; 103(2): 489-498, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37999763
2.
Impact of busulfan versus treosulfan dose intensity in myelofibrosis undergoing hematopoietic cell transplantation.
Am J Hematol
; 2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38742955
3.
Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post-transplant cyclophosphamide in AML in first complete remission.
Br J Haematol
; 201(6): 1169-1178, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36949658
4.
SARS-CoV-2-specific T cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID-19 vaccination.
Eur J Immunol
; 52(7): 1194-1197, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35389515
5.
Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease.
J Transl Med
; 21(1): 837, 2023 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37990219
6.
Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AML.
Ann Hematol
; 102(10): 2903-2908, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37552323
7.
Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia.
Cancer
; 128(15): 2922-2931, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35612815
8.
External validation of models for KIR2DS1/KIR3DL1-informed selection of hematopoietic cell donors fails.
Blood
; 135(16): 1386-1395, 2020 04 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-31932846
9.
Twenty years of experience of a tertiary cancer center in total body irradiation with focus on oncological outcome and secondary malignancies.
Strahlenther Onkol
; 198(6): 547-557, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35318487
10.
Allogeneic transplant procurement in the times of COVID-19: Quality report from the central European cryopreservation site.
J Transl Med
; 19(1): 145, 2021 04 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33832504
11.
Efficacy of UVC-treated, pathogen-reduced platelets versus untreated platelets: a randomized controlled non-inferiority trial.
Haematologica
; 106(4): 1086-1096, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33538149
12.
Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q).
Ann Hematol
; 100(6): 1463-1471, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33903952
13.
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group.
Ann Hematol
; 100(4): 959-968, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33191481
14.
Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Haematologica
; 105(6): 1507-1516, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32241850
15.
Reducing the red blood cell transfusion threshold from 8·0 g/dl to 7·0 g/dl in acute myeloid leukaemia patients undergoing induction chemotherapy reduces transfusion rates without adversely affecting patient outcome.
Vox Sang
; 115(7): 570-578, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32342521
16.
Clearance of Hematologic Malignancies by Allogeneic Cytokine-Induced Killer Cell or Donor Lymphocyte Infusions.
Biol Blood Marrow Transplant
; 25(7): 1281-1292, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30878607
17.
Biology-Driven Approaches to Prevent and Treat Relapse of Myeloid Neoplasia after Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(4): e128-e140, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30658222
18.
Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia - a matched pair analysis by the Acute Leukaemia Working Party of EBMT.
Br J Haematol
; 184(5): 782-787, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30467839
19.
Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial.
Lancet Oncol
; 19(12): 1668-1679, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30442503
20.
A Modified Post-Transplant Cyclophosphamide Regimen, for Unmanipulated Haploidentical Marrow Transplantation, in Acute Myeloid Leukemia: A Multicenter Study.
Biol Blood Marrow Transplant
; 24(6): 1243-1249, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29421292